HIV/AIDS Topics FDA Approves Truvada PrEP for Prevention of Sexually Transmitted HIV Infection
- Details
- Category: HIV Prevention
- Published on Monday, 16 July 2012 00:00
- Written by Liz Highleyman
On July 16, 2012, the U.S. Food and Drug Administration (FDA) approved Truvada -- Gilead Sciences' tenofovir/emtricitabine combination pill -- for pre-exposure prophylaxis (PrEP) to prevent sexual transmission of HIV.
HIV PrEP Can Be Highly Effective, but Only if Used Consistently
- Details
- Category: HIV Prevention
- Published on Friday, 13 July 2012 00:00
- Written by Liz Highleyman
Pre-exposure prophylaxis (PrEP) with tenofovir or Truvada can dramatically lower the risk of HIV sexual transmission for heterosexual men and women -- as has previously been shown for gay men -- but good adherence is crucial to its success, according to a trio of studies published in the July 11, 2012, advance online edition of the New England Journal of Medicine.
CDC Review Finds No Link Between Hormonal Contraception and HIV Risk
- Details
- Category: HIV Sexual Transmission
- Published on Wednesday, 27 June 2012 00:00
- Written by Liz Highleyman
A data review by the U.S. Centers for Disease Control and Prevention (CDC) has failed to confirm a previously described association between injectable or oral hormonal contraceptives and increased likelihood of HIV infection or disease progression, researchers reported in the June 22, 2012, issue of Morbidity and Mortality Weekly Report.
Bathhouses Can Be Good Venues for HIV Testing and Linkage to Care
- Details
- Category: HIV Prevention
- Published on Friday, 29 June 2012 00:00
- Written by Liz Highleyman
Bathhouses frequented by gay and bisexual men may be good places to find people with undiagnosed HIV or other sexually transmitted diseases and encourage them to enter ongoing care, researchers reported in the February 1, 2012, Journal of Acquired Immune Deficiency Syndromes. 
Researchers Describe Ethical Challenges of Treatment as Prevention Trial
- Details
- Category: Treatment as Prevention
- Published on Friday, 22 June 2012 00:00
- Written by Liz Highleyman
As described in the June 2012 issue of Clinical Trials, large trials looking at HIV prevention and other public health interventions -- especially those conducted in resource-limited settings -- may face ethical issues that could affect the validity of study findings.
More Articles...
- Dapivirine Vaginal Ring HIV Prevention Trial Launched in Africa
- U.S. Agencies Recommend Blunt Suture Needles to Reduce Risk of Viral Hepatitis and HIV
- June 13: 'Rethinking MSM' Webinar on Politics of Identity in HIV Prevention
- African Study Finds HIV Superinfection May be as Common as Initial Infection
Web Design and Development by